Overall, our study underscores the therapeutic potential of TBM-2 for the treatment of HCC and highlights the importance of the MKK4–p38α axis and lipid metabolism, especially cholesterol biosynthesis, in the process of methuosis. This evidence concerns the gene MAP2K4 and hepatocellular carcinoma.